Vascular Access creation in the US A surgical perspective. Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery

Size: px
Start display at page:

Download "Vascular Access creation in the US A surgical perspective. Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery"

Transcription

1 Vascular Access creation in the US A surgical perspective Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery

2 Disclosures No specific disclosures pertaining to the topic of presentation

3 Vascular Access in US Surgical perspective.. Background 50 th Anniverseryof Internal (access) shunts Cimino Appel Brescia Brescia XXX Cimino XXX Appel XXX Cimino Appel Brescia Brescia MJ, Cimino JE, Appel K, Hrwich BJ NEJY;1966:1089

4 Vascular Access in US Surgical perspective Background Health care changes in US: Impact on VA Social Security Amendments 1972 All persons with ESRD eligible for medicare Assured reimbursement Improved access to healthcare Increased experience better care and longevity Physician s Behavioral change Patient profile: elderly, diabetics, co morbidities Beneficiaries 10,000 (1970) to >150,000 (1990) USRDS ADR Ch XII 1994

5 Vascular Access in US Surgical perspective. Fistulae better than shunts Need for anatomic suitability Maturation period Uncertainty of success Biologic Xenografts Cross linked Bovine carotid artery (Artegraft, Artegraft Inc) AVF Background Problems with vascular access Cross link Non cross linked non antigenic AVG Allograft Human Umbilical vein (Biograft, Meadox Meds) - Saphenous vein Synthetic 1976 Non cross linked - eptfe Cryopreserved (1985) antigenic Multitudes of sites with very little technical changes Snuff box, high & low wrist fistula, brachiocephalic, Gracz AVF, basilica transposition UA, basilic transposition FA No attention paid to cause of failure no need due to short longevity

6 Vascular Access in US Surgical perspective. Background US ESRD population (200,000) Japan ESRD (175,00) European ESRD (30,000) NKF-KDOQI (1995) Fistula First (2003) ~ 80% AVG ~ 85% AVF ~ 80% AVF Access population differences Access modality differences Outcome differences Goodkin DA et.al. JASN 2003; 14: 3270 Schena FP Kidney Int 2000; 57: S39-45

7 Strategies to improve ESRD mortality Decreased BP Decreased LVH (2000-present) RAS inhibitors, statins, BP control, Phos control, fluid control etc. Increased dialysis dose Improved QOL Phos control Quality of dialysis depends on functioning of vascular access AVG, Catheters and AVF Better nutrition Williams AW. AJKD 2004;43:90 Kliger AS. CJASN 2009;4:S121

8 Vascular access practice patterns Access performed by well-trained surgeons Surgeons trained in graft era Minimal experience in AVF Access = joining a vein/graft to artery High rates of primary failure TDC prevalence Origin and proliferation of image guided procedures and devices and catheter industry Adaptation of medical community to changing practice pattern Dember LM et.al. JAMA 2008;299: Lacson E, et.al. AJKD 2007; 50:379-95

9 Individual data AVF 79% AVG 21% Functional AVF maturation 81.7% Committed to catheter 3.5% AVF maturation (ITT) 72% 1 yr. Primary patency 42.5% 1 yr. Secondary patency 81.8 % Median (range mon) followup 36.1 mon AVF procedures per functional year 0.68 Patient outcome >85% AVF

10 VA creation: Changing outcome Richardson AI et.al. JVA 2009; 10: Dember LM et.al. JAMA 2008;299: Jennings WC. Arc Surg 2006; 141:27-32 Lucas J. J Vasc Surg 2016;

11 VA surgical practice patterns Large Academic Medical center ~ 300 cases in 1 year by 8 surgeons 2 Surgeons performed >60% of procedures These surgeons performed >80% AVF One recent trainee also performed >80% AVF Other surgeons performed AVF ~ 50% patients Patterns reflect a changing practice patterns showing improvement in training and importance of access champions Vachharajani N,et.al. J Vasc Surg 2015: s1-s4

12 VA patterns in incident patients CMS 2728 & crown web data 2013 Catheter 20% 80% 17% AVF 65% USRDS 2015

13 Vascular access surgical training Vascular Board certification data 300% increase in AVF (5 in 2003 to 18) VA is considered a resident case 19 residents graduated between Required vascular cases 44 Average AVF/AVG(range 11-73) 33 Revisions (range 1-27) 11 Trainees interested in VA 62 Eidt JF. JVS 2011; 53: Current surgical training provides ample opportunity Vachharajani N,et.al. J Vasc Surg 2015: s1-s4

14 What are some issues? Difficulty to make AVA attractive High rates of failure Lack of scientific understanding Lack of innovative research Multidisciplinary nature of the practice Fragmentation of care Lack of advocacy

15 Physiology: AVA maturation & failure Central outflow Capacity of the pump diameter, stiffness & length of the tubes determines the flow Inflow Peripheral Outflow NAS (Needle access Segment) AVG is NAS of the circuit Stenosis is the cause for majority of access circuit failure

16 Where we are now? Total ESRD population ~661,648 Hemodialysis (91%) ~421,000 Peritoneal Dialysis (9%) ~ 45,000 Post transplant ~ 193,000 ~ 117,000 patients started dialysis in 2012 Growing patient population will propel changes in the field USRDS 2015

17 Summary Surgical problems associated with vascular access were part of the evolution of the speciality. The current eduction system is robust enough to adjust the need of the changing practice patterns. There is a need for better understanding and research in the field to improve the current outcome Increasing prevalence of ESRD will continue to fuel the progress and innovation

18 Vascular Access creation in the US A surgical perspective

19

KDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium

KDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium DISCLOSURES: NONE Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium KDOQI Guidelines AV fistulas have better outcomes than grafts or catheters

More information

ASDIN 7th Annual Scientific Meeting

ASDIN 7th Annual Scientific Meeting Strategies for Decreasing the Use of Hemodialysis Catheters ASDIN 7 th Annual Scientific Meeting Outline Late referral Primary failure Why Not PD? Summary Micah Chan MD MPH FACP Assistant Professor of

More information

Pitfalls in pushing fistulas ----

Pitfalls in pushing fistulas ---- Pitfalls in pushing fistulas ---- An argument for more grafts Marc Webb, MD, FACS Michigan Vascular Access, PC March 27 th, 2009 Vascular Access for Hemodialysis ------- Basic facts - the need for Access

More information

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Jesus Contreras, D.O. PGY-4 John Yasmer, D.O. Department of Radiology No Disclosures Objectives Introduce

More information

Percutaneous AV Fistula Creation. Ellipsys EndoAVF System

Percutaneous AV Fistula Creation. Ellipsys EndoAVF System Percutaneous AV Fistula Creation Ellipsys EndoAVF System Presented by Forest Rawls Jr CHT,CCHT-A,FNKF No Disclosures Various Access Types Some old Some new Scribner Shunt OUR OLD DEPENDABLE FRIEND

More information

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face Sid Bhende MD Sentara Vascular Specialists April 28 th 2018 Dialysis Access Review: Understanding the Access Options our Patients Face Disclosures Dialysis Background Why is it important? Outline National

More information

Preservation of Veins and Timing for Vascular Access

Preservation of Veins and Timing for Vascular Access Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access

More information

Fistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting

Fistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting Fistula First "Unassisted" evaluation of access dysfunction (eyes, ears, and fingers) Tushar Vachharajani, MD Chief, Nephrology Section W. G. (Bill) Hefner VAMC Salisbury, NC Quality improvement projects

More information

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute Disclosures No relevant disclosures Employee Advanced Access Care Dialysis Work 5 operating surgeons 3

More information

Jimmy Wei Hwa Tan, Surg, MD

Jimmy Wei Hwa Tan, Surg, MD Jimmy Wei Hwa Tan, Surg, MD Director, Department of Surgery Chief, Department of Cardiovascular Surgery Tainan An-Nan Municipal Hospital, China Medical University, Taiwan Disclosure I have the following

More information

Vascular Access for Haemodialysis. Mike Stephens

Vascular Access for Haemodialysis. Mike Stephens Vascular Access for Haemodialysis Mike Stephens Overview Learning Objectives History and development of vascular access Standards in vascular access surgery Types of vascular access Complications Objectives

More information

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care CATHETER REDUCTION Angelo N. Makris, M.D. Medical Director Chicago Access Care Objectives Discuss tools/techniques proven to improve AVF rates & decrease catheter rates Implement a change process in your

More information

Hemodialysis Fistula Maturation Consortium

Hemodialysis Fistula Maturation Consortium Hemodialysis Fistula Maturation Consortium Rationale for Fistula Maturation Study Dialysis Access Consortium AVF study 60% of new AVFs were unusable for dialysis at 4-5 months post surgery No predictors

More information

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose Local elastase to aid fistula maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2013 UCSF Vascular Symposium I have nothing to disclose AVF Prevalence 60.6% (April 2012) Fistula First Initiative

More information

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators IN.PACT AV Access IDE Study Full Baseline Data Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators Disclosures Speaker name: Robert Lookstein, MD... I have the following

More information

2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi

2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi Stage 5 Chronic Kidney Disease Assessing the Results of AV Access: Realistic Outcomes in 2009 Sean P. Roddy, MD Albany, NY Defined as a GFR

More information

Medical Director/Surgeon as Partners WebEx February 11, 2010

Medical Director/Surgeon as Partners WebEx February 11, 2010 Medical Director/Surgeon as Partners WebEx February 11, 2010 Over 400,000 patients are treated yearly for ESRD in the USA; 60% of these patients receive some form of hemodialysis Despite major advances

More information

Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?

Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB? Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB? Martin Forlee Vascular Surgeon Cape Town Disclosure Speaker name: Martin Forlee I have the following potential conflicts of interest

More information

Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database

Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database ORIGINAL ARTICLE Korean J Intern Med 218;33:116-1168 https://doi.org/1.394/kjim.218.17 Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health

More information

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next No Cephalic Vein What s Next End Stage Renal Disease Charles Eichler MD Clinical Professor of Surgery Division of Vascular Surgery UCSF April 5, 2014 Population of patients with ESRD growing rapidly -

More information

UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC

UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC Background Endovascular AVF Outline Data from FLEX and NEAT study SPH data Clinical experience Cannulation

More information

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF Why Can t I Cannulate This Access? Steven J. Bander M.D. Adjunct Professor of Nephrology St. Louis University Director, Vascular Access Center, St. Luke s Hospital Saint Louis, MO Why Can't I Cannulate

More information

Incident Hemodialysis

Incident Hemodialysis The Acute Kidney Injury Group Modifying the Highest Mortality Rate in the Major AKI Adverse Outcome Other than Death: Loss ESRD & Incident Hemodialysis The EVA QI Program Integrated Inpatient Early Vascular

More information

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage

More information

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts

More information

NKF K/DOQI GUIDELINES

NKF K/DOQI GUIDELINES NKF K/DOQI GUIDELINES Executive Summaries Anemia Hemodialysis Peritoneal Dialysis Vascular Access Nutrition CKD 2002 Dyslipidemias Bone Metabolism Hypertension and Antihypertensive Agents Cardiovascular

More information

Difference in practical dialysis therapy between East Asia and US/EU

Difference in practical dialysis therapy between East Asia and US/EU Difference in practical dialysis therapy between East Asia and US/EU Jer-Ming Chang. M.D., Ph.D. 1 Professor, Attending physician, Kaohsiung Medical University Hospital; 2 Secretary General, Taiwan Society

More information

Il paziente anziano, evidenza e survey nazionale

Il paziente anziano, evidenza e survey nazionale Università La Sapienza Scuola di Specializzazione in Nefrologia Prof P. Menè Meeting di Nefrololgia Interventistica L Accesso Vascolare Impossibile Roma 23 Marzo 2016 Il paziente anziano, evidenza e survey

More information

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is a

More information

Steal Syndrome: The Role of the Vascular Lab

Steal Syndrome: The Role of the Vascular Lab Steal Syndrome: The Role of the Vascular Lab Eighth Overlook Noninvasive Vascular Lab Symposium Larry A. Scher, M.D. Professor of Surgery Division of Vascular Surgery Montefiore Medical Center Albert Einstein

More information

PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S

PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S THE INCREASE IN THE CONSTRUCTION OF AUTOGENOUS FISTULAE OVER THE PAST TEN YEARS HAS BROUGHT WITH IT 1.

More information

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University

More information

Utopia Health Career Center, LLC. Do not distribute without permission.

Utopia Health Career Center, LLC. Do not distribute without permission. Introduction What is dialysis and a brief history. What laws govern dialysis treatments. How to ensure high quality care for patients. How to behave in a professional way. How to become certified. We don

More information

Thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure)

Thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure) Dialysis Vascular Access Coverage, Coding and Reimbursement Overview Hospital Outpatient 2019 Edition All Reimbursement Amounts are Listed at ational Unadjusted Medicare Rates and Do ot Include the 2%

More information

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access Theodore F. Saad, MD Nephrology Associates, PA Christiana Care Health System Newark, Delaware Cardiovascular Implantable

More information

AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS

AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS Vascular Access New Technology What problem are you trying to solve for? Most common problem is inadequate outflow

More information

ASDIN 8th Annual Scientific Meeting

ASDIN 8th Annual Scientific Meeting Fistula First Breakthrough Initiative Fistula First Breakthrough Initiative Marianne Neumann, RN, CNN FFBI Clinical Lead New Orleans, LA February 26, 2012 Initiated in 2003 by CMS, Goals Include: to ensure

More information

The vexing problem of suboptimal initiation of dialysis: Can we do better?

The vexing problem of suboptimal initiation of dialysis: Can we do better? Budapest Nephrology School August 30, 2010 The vexing problem of suboptimal initiation of dialysis: Can we do better? David C Mendelssohn Disclosures 2007 2010 Speaker Fees: Amgen, Ortho Biotech, Genzyme,

More information

HD Scanning: Velocities and Volume Flow

HD Scanning: Velocities and Volume Flow HD Scanning: Velocities and Volume Flow Non-Invasive Lab Symposium West Orange, NJ April 27, 2018 Volume Flow Cindy Sturt, MD, FACS, RVT 500,000 Americans on dialysis 20-25% annual mortality 65% 5 year

More information

Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access

Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access From the Society for Clinical Vascular Surgery Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access Robert B. McLafferty, MD, Raymond W. Pryor

More information

Lutonix in AV fistula and Early look AV IDE trial data

Lutonix in AV fistula and Early look AV IDE trial data Lutonix in AV fistula and Early look AV IDE trial data Jackie P Ho Dept of Cardiac, Thoracic & Vascular Surgery National University of Singapore NUHS, Singapore Lutonix in AV fistula and final AV IDE trial

More information

JVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE

JVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE JVA ISSN 1129-7298 J Vasc Access 2015; 16 (Suppl 9): S11-S15 DOI: 10.5301/jva.5000366 ORIGINAL ARTICLE Hemodialysis vascular access management in the Netherlands Jan H.M. Tordoir 1, Magda M. van Loon 1,

More information

Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:

More information

Explorations fonctionnelles des abords vasculaires pour hémodialyse

Explorations fonctionnelles des abords vasculaires pour hémodialyse Explorations fonctionnelles des abords vasculaires pour hémodialyse Frank Le Roy Nephrology Department Actualités Néphrologiques Jean Hamburger Necker, 27 avril 2015 1966 Brescia, Cimino, Appel, Hurwich.

More information

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center The HeRO Graft Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center Faculty Disclosure I disclose the following financial relationships: CryoLife/Hemosphere, Inc. & W.L. Gore and

More information

mean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20).

mean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20). S44 Figure 53 depicts the trend in Epoetin dosing from the 1998 study period to the 2003 study period, with an increasing mean weekly Epoetin dose (units/kg/wk) for patients prescribed Epoetin in lower

More information

A New Technique to Superficialize Arteriovenous Fistulas Too Deep for Reliable Cannulation

A New Technique to Superficialize Arteriovenous Fistulas Too Deep for Reliable Cannulation A New Technique to Superficialize Arteriovenous Fistulas Too Deep for Reliable Cannulation Danielle Fontenot, MD, MS Adam Tanious, MD, MMSc, Yusuf Chauhan, BS Alicia Stafford, BS, Karl A. Illig, MD University

More information

First experience with DCB for treatment of dialysis access stenosis The Greek experience

First experience with DCB for treatment of dialysis access stenosis The Greek experience First experience with DCB for treatment of dialysis access stenosis The Greek experience D Karnabatidis Department of Interventional Radiology Patras University Hospital Patras, Greece Background Vessel

More information

Impact of secondary procedures in autogenous arteriovenous fistula maturation and maintenance

Impact of secondary procedures in autogenous arteriovenous fistula maturation and maintenance Impact of secondary procedures in autogenous arteriovenous fistula maturation and maintenance Scott S. Berman, MD, FACS, and Andrew T. Gentile, MD, Tucson, Ariz Purpose: The purpose of this study was to

More information

Chapter 2 Proximal Forearm Arteriovenous Fistula Creation

Chapter 2 Proximal Forearm Arteriovenous Fistula Creation Chapter 2 Proximal Forearm Arteriovenous Fistula Creation Venkat Kalapatapu and Andre Ramdon Introduction Worldwide greater than two million patients need renal replacement therapy. The aging population

More information

Focus su: Accessi Vascolari. dr Carlo Lomonte U.O.C. di Nefrologia e Dialisi Ente Ecclesiastico Ospedale Miulli Acquaviva delle Fonti - Ba

Focus su: Accessi Vascolari. dr Carlo Lomonte U.O.C. di Nefrologia e Dialisi Ente Ecclesiastico Ospedale Miulli Acquaviva delle Fonti - Ba Focus su: Accessi Vascolari dr Carlo Lomonte U.O.C. di Nefrologia e Dialisi Ente Ecclesiastico Ospedale Miulli Acquaviva delle Fonti - Ba Sommario Epidemiologia dell Accesso Vascolare L Accesso Vascolare

More information

Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward?

Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward? Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward? Maurizio Gallieni Nephrology and Dialysis Unit Ospedale S. Carlo Borromeo, ASST Santi Paolo e Carlo,

More information

Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is

More information

Role of Covered Stents and Drug Eluting Balloons In Dialysis Access

Role of Covered Stents and Drug Eluting Balloons In Dialysis Access Role of Covered Stents and Drug Eluting Balloons In Dialysis Access Joseph Habib, MD, FACS Assistant Professor Department of Surgery Division of Vascular and Endovascular Surgery University of Florida

More information

Developing a Quality Assurance Performance Improvement (QAPI) Program at Your Dialysis Center Rudolph P. Valentini, M.D. Associate Professor of Pediatrics Director of Dialysis Services Vice Chief of Staff

More information

Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand

Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB Andrew Holden Auckland Hospital Auckland, New Zealand LINC 2017 26 th January 2017 Disclosure Speaker name: Andrew Holden I have

More information

Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys vascular access system

Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys vascular access system Hemodialysis International 2019 Original Article Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys vascular access system Hedia HEBIBI, 1,2,3 Jedjiga

More information

REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange

REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange Agenda History of the Medicare ESRD Program Cost of Care for ESRD Patients

More information

Regardless of whether you are a vascular surgeon,

Regardless of whether you are a vascular surgeon, C A S E R E P O R T The Versatility of the GORE VIABAHN Endoprosthesis Several case reports highlighting its unique design and why it is a valuable tool for the interventionist. BY PETER WAYNE, MD Regardless

More information

Bare Metal Stents vs Stent Grafts

Bare Metal Stents vs Stent Grafts Bare Metal Stents vs Stent Grafts ASDIN 12th Annual Scientific Meeting Phoenix, AZ, February 20, 2016 Dirk Hentschel, MD Director, Interventional Nephrology Brigham and Women s Hospital Disclosure Consultant:

More information

Internationally, the arteriovenous fistula (AVF)

Internationally, the arteriovenous fistula (AVF) IN THE LITERATURE More Than Reducing Early Fistula Thrombosis Is Required: Lessons From the Dialysis Access Consortium Clopidogrel Fistula Study Commentary on Dember LM, Beck GJ, Allon M, et al: Effect

More information

Vascular Access for Patients affected by non Renal Disorders. Eric S Chemla St George s vascular Institute London UK

Vascular Access for Patients affected by non Renal Disorders. Eric S Chemla St George s vascular Institute London UK Vascular Access for Patients affected by non Renal Disorders Eric S Chemla St George s vascular Institute London UK Disclosures Gore Covidien Maquet Proteon Therapeutics INTRODUCTION I First fistula in

More information

LUTONIX AV Clinical Trial

LUTONIX AV Clinical Trial LUTONIX AV Clinical Trial A Prospective, Global, Multicenter, Randomized, Controlled Study Comparing LUTONIX 035 AV Drug Coated Balloon PTA Catheter vs. Standard Balloon PTA Catheter for the Treatment

More information

*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD

*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD The views presented reflect those of the author/presenter and do not necessarily reflect those of ASDIN nor serve as an endorsement of safety, efficacy or applicability of said procedure. the Endovascular

More information

Cephalic Arch Stenosis: A unique entity

Cephalic Arch Stenosis: A unique entity Cephalic Arch Stenosis: A unique entity Arif Asif, M.D. Professor of Medicine Director, Interventional Nephrology University of Miami, Miami, FL PUMP Kian K, Asif A: Semin Dial 2008 Prevalence of CAS 39%

More information

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS DISCLOSURES UTILITY OF ULTRASOUND IN EVALUATING ACCESS DYSFUNCTION None Vandana Dua Niyyar, MD Assistant Professor of Medicine, Division of Nephrology, Emory University UTILITY OF ULTRASOUND IN ACCESS

More information

Distal Hypoperfusion Ischemic Syndrome (DHIS)

Distal Hypoperfusion Ischemic Syndrome (DHIS) Pathophysiology Traditional View ( Steal Syndrome ) Distal Hypoperfusion Ischemic Syndrome (DHIS) Steven Wu, MD Director of Interventional Nephrology Massachusetts General Hospital Harvard Medical School

More information

Chapter Five Clinical indicators & preventive health

Chapter Five Clinical indicators & preventive health Chapter Five Clinical indicators & preventive health The painter who draws merely by practice and by eye, without any reason, is like a mirror which copies every thing placed in front of it without being

More information

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name: Dr

More information

COVERA Vascular Covered Stents Innovation in AV Access

COVERA Vascular Covered Stents Innovation in AV Access IL0118 Rev.0 1 COVERA Vascular Covered Stents Innovation in AV Access Dheeraj Rajan, MD, FRCPC, FSIR Head and Associate Professor, Division of Vascular & Interventional Radiology Department of Medical

More information

Supera for the Juxta-anastomotic AVF Stenosis

Supera for the Juxta-anastomotic AVF Stenosis Supera for the Juxta-anastomotic AVF Stenosis Dr Shannon D. Thomas Vascular Access Surgeon Conjoint Senior Lecturer University of New South Wales Sydney, Australia Disclosure Speaker name: Dr S. D. Thomas...

More information

Evaluation of AVF and AVG

Evaluation of AVF and AVG Evaluation of AVF and AVG 2013 Nephrology Nursing Symposium Albuquerque Vascular Access Leading cause of hospitalization in the ESRD population Annual cost approaching $1.5 billion (USRDS, 2004) Current

More information

Anesthetic Options for Patients Undergoing Dialysis Access Procedures Derek T. Woodrum, M.D. University of Michigan Hospitals, Ann Arbor, MI

Anesthetic Options for Patients Undergoing Dialysis Access Procedures Derek T. Woodrum, M.D. University of Michigan Hospitals, Ann Arbor, MI Session: L151 Session: L234 Anesthetic Options for Patients Undergoing Dialysis Access Procedures Derek T. Woodrum, M.D. University of Michigan Hospitals, Ann Arbor, MI Disclosures: This presenter has

More information

Early adopters and clinical investigators of percutaneous. The SIR 2016 Panel on Endovascular Arteriovenous Fistula Creation

Early adopters and clinical investigators of percutaneous. The SIR 2016 Panel on Endovascular Arteriovenous Fistula Creation The SIR 2016 Panel on Endovascular Arteriovenous Fistula Creation Highlights from an expert panel held at the Society of Interventional Radiology s 2016 annual scientific sessions, including summaries

More information

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance Hemodialysis Access Surveillance Postoperative AV Fistula Evaluation Failure of maturation Stenosis Perigraft mass/fluid collection Joseph L. Mills, Sr., M.D. Professor of Surgery Chief, Division of Vascular

More information

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA & TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA 2002-2008 Halima Resić* 1, Enisa Mešić 2 1 Clinic for Hemodialysis, University of Sarajevo Clinics Centre, Bolnička 25, 71000 Sarajevo, Bosnia

More information

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program Global Journal of Health Science; Vol. 8, No. 10; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Decreased Incidence of Clotted AV Access in Hemodialysis Patients

More information

Omniflow II biosynthetic vascular prosthesis

Omniflow II biosynthetic vascular prosthesis Omniflow II biosynthetic vascular prosthesis A unique solution to challenging clinical situations Designed to resemble autologous vein Haemocompatible Smooth, non-thrombogenic flow surface Good long-term

More information

De dialysefistel: snel maken, snel staken? Joris Rotmans, internist-nefroloog Afdeling Interne Geneeskunde Leids Universitair Medisch Centrum

De dialysefistel: snel maken, snel staken? Joris Rotmans, internist-nefroloog Afdeling Interne Geneeskunde Leids Universitair Medisch Centrum Workshop Nefrologie Papendal 12 December 2018 De dialysefistel: snel maken, snel staken? Joris Rotmans, internist-nefroloog Afdeling Interne Geneeskunde Leids Universitair Medisch Centrum Disclosure belangen

More information

Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital

Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital Button hole or Ladder?? Vascular Access Cannulation It s a Life Line of Hemodialysis patient Arterio-venous fistula(avf) is the K/DOQI

More information

Cost Analysis of the Creation and Maintenance of Functional Arteriovenous Grafts for Hemodialysis

Cost Analysis of the Creation and Maintenance of Functional Arteriovenous Grafts for Hemodialysis Cost Analysis of the Creation and Maintenance of Functional Arteriovenous Grafts for Hemodialysis Neeraja Konuthula BS, Steven D. Abramowitz MD, Harry Schanzer MD, Peter L. Faries MD, Michael L. Marin

More information

Selection of Permanent Hemodialysis Vascular Access

Selection of Permanent Hemodialysis Vascular Access Selection of Permanent Hemodialysis Vascular Access TABLE OF CONTENTS 1.0 Scope...1 2.0 Recommendations & Rationale... 2 3.0 References... 3 4.0 Sponsors... 9 5.0 Effective Date... 10 Appendix 1: Key Elements

More information

Sonographic Evaluation of an Immature Brescia-Cimino Fistula

Sonographic Evaluation of an Immature Brescia-Cimino Fistula 696792JDMXXX10.1177/8756479317696792Journal of Diagnostic Medical SonographyChappell research-article2017 Case Study Sonographic Evaluation of an Immature Brescia-Cimino Fistula Journal of Diagnostic Medical

More information

Endovascular Should Be Considered First Line Therapy

Endovascular Should Be Considered First Line Therapy Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach

More information

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access Vascular and Interventional Radiology Review Shenoy and Darcy Ultrasound in Dialysis Interventions Vascular and Interventional Radiology Review FOUS ON: Surendra Shenoy 1 Michael Darcy 2 Shenoy S, Darcy

More information

Lutonix AV Clinical Trial

Lutonix AV Clinical Trial Long Term Effects of LUTONIX 035 DCB Catheter Interim 24 Month Results Ta-Wei Su MD Vascular surgery CGMH Taiwan Disclosure I have the following potential conflicts of interest to report: Consulting Employment

More information

Brachial vein transposition arteriovenous fistulas for hemodialysis access

Brachial vein transposition arteriovenous fistulas for hemodialysis access From the Society for Vascular Surgery Brachial vein transposition arteriovenous fistulas for hemodialysis access William C. Jennings, MD, Matthew J. Sideman, MD, Kevin E. Taubman, MD, and Thomas A. Broughan,

More information

Vein diameter is the major predictor of fistula maturation

Vein diameter is the major predictor of fistula maturation From the Western Vascular Society Vein diameter is the major predictor of fistula maturation Lannery S. Lauvao, MD, Daniel M. Ihnat, MD, Kaoru R. Goshima, MD, LeAnn Chavez, MD, Angelika C. Gruessner, MS,

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 10: Dialysis Providers In 2013, collectively the three large dialysis organizations treated 71% of patients in 67% of all dialysis units. In the Small Dialysis

More information

COVERA covered stent to treat stenosis in arteriovenous fistula: 6-month results from the prospective, multi-center, randomized AVeNEW study

COVERA covered stent to treat stenosis in arteriovenous fistula: 6-month results from the prospective, multi-center, randomized AVeNEW study COVERA covered stent to treat stenosis in arteriovenous fistula: 6-month results from the prospective, multi-center, randomized AVeNEW study Panagiotis Kitrou MD, MSc, PhD, EBIR Consultant Interventional

More information

Disclosure. Speaker name: Prof. Hesham Aly Sharaf El-Din. I do not have any potential conflict of interest

Disclosure. Speaker name: Prof. Hesham Aly Sharaf El-Din. I do not have any potential conflict of interest Disclosure Speaker name: Prof. Hesham Aly Sharaf El-Din I do not have any potential conflict of interest Introduction 5% of patients with upper limb AVF develop ipsilateral hand ischemia, recently termed

More information

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,

More information

Time to Reduce Mortality in End Stage Renal Disease (TiME)

Time to Reduce Mortality in End Stage Renal Disease (TiME) Time to Reduce Mortality in End Stage Renal Disease (TiME) A Large, Pragmatic Cluster Randomized Trial in Maintenance Hemodialysis Laura M. Dember, M.D. on behalf of the TiME Trial Study Group NIH HCS

More information

Experience with Arteriovenous Fistulas for Chronic Hemodialysis in Pediatric Age Group. Nehad Zaid

Experience with Arteriovenous Fistulas for Chronic Hemodialysis in Pediatric Age Group. Nehad Zaid Experience with Arteriovenous Fistulas for Chronic Hemodialysis in Pediatric Age Group Nehad Zaid Vascular Surgery Unit, General Surgery Department, Menoufiya University Hospitals nehadzaid@yahoo.com Abstract:

More information

4/30/2014. In Vitro Study of AVF Outflow Vein Wall Shear Stress and Pulse Pressure

4/30/2014. In Vitro Study of AVF Outflow Vein Wall Shear Stress and Pulse Pressure In Vitro Study of AVF Outflow Vein Wall Shear Stress and Pulse Pressure 1 Disclosures Employees & Consultants: H.M. Loree 1, F.N. Franano 1, G. Agyapong 1, E.G. Bailey 1, G.A. Ngai 1, G.D. Tansley 2 Equity

More information

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions Central Venous Stenoses and Occlusions Management of Central Vein Stenoses Robert K. Kerlan Jr. M.D. Professor of Clinical Radiology and Surgery University of California San Francisco Key Questions What

More information

Superficialización de la vena basílica. Pierre BOURQUELOT, Paris

Superficialización de la vena basílica. Pierre BOURQUELOT, Paris Superficialización de la vena basílica. Pierre BOURQUELOT, Paris 1 Basilic Vein Superficialization. Pierre BOURQUELOT, Paris 2 (Upper arm) Basilic Vein 3 Technique 2-stage Basilic Vein Tunnel-Superficialization

More information

Vascular a ccess access for Dialysis a surgeon s perspecti e v. some observations

Vascular a ccess access for Dialysis a surgeon s perspecti e v. some observations Vascular access for Dialysis a surgeon s perspective e. some observations Age of New Haemodialysis Patients 2005 Australia Number (Total=1957) 0.7% 3% 5% 10% 15% 20% 26% 19% 2% 0-14 15-24 25-34 35-44

More information

Lutonix AV Clinical Trial

Lutonix AV Clinical Trial Long Term Effects of LUTONIX 035 DCB Catheter Interim 24 Month Results Scott O. Trerotola, MD, for the Lutonix AV Investigators Stanley Baum Professor of Radiology Professor of Radiology in Surgery Associate

More information

Coding of Procedures in Interventional Nephrology Produced in collaboration with:

Coding of Procedures in Interventional Nephrology Produced in collaboration with: Coding of Procedures in Interventional Nephrology 2013 Produced in collaboration with: Introduction Proper coding of interventional procedures is a difficult and daunting, but essential task. Each procedure

More information